688266.SS · 泽璟制药
China A-shares · RS rating 32 · As of 2026-10-14
| Price | 96.60 CNY |
|---|---|
| 1-day change | -2.4% |
| RS rating (overall / 1M / 3M / 12M) | 32 / 11 / 13 / 58 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 32 / 24 / 17 |
| Industry group (rank) | Medical-Biomed/Biotech (68) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -66.9% |
| Distance from 52-week high | +34.5% |
| Market cap (USD) | $4.1B |